BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5533303)

  • 21. [Personal experience on the use of glybenclamide (a new oral hypoglycemic agent)].
    Rodríguez-Miñón JL; Arrieta F; Herrera JL
    Rev Clin Esp; 1970 May; 117(4):371-4. PubMed ID: 5471526
    [No Abstract]   [Full Text] [Related]  

  • 22. [Modern oral sugar-reducing drugs: focus to glibenclamide].
    Ushakova EA
    Ter Arkh; 2007; 79(12):86-90. PubMed ID: 18220041
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of type 2 diabetes. Effective control of postprandial glucose surges].
    MMW Fortschr Med; 2001 Jul; 143(28-29):56-7. PubMed ID: 11499153
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma insulin and metabolic study on diabetes treated with glibenclamide.
    Anderson J; Coulson R; Grassick BD; Morris BA; Thomas WD; Tomlinson RW; Woodroffe F
    Postgrad Med J; 1970 Dec; ():Suppl:36-41. PubMed ID: 5533294
    [No Abstract]   [Full Text] [Related]  

  • 25. [Oral hypoglycemic agents in the treatment of elderly diabetics].
    Oba K
    Nihon Ronen Igakkai Zasshi; 2001 May; 38(3):288-90. PubMed ID: 11431871
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinico-therapeutic experiences with the new hypoglycemic sulfanylurea, glibenclamide].
    Arena D; Santeusanio F; Puxeddu A; De Ciuceis P; Migliorini E; Siracusa A; Brunetti P
    Clin Ter; 1970 Mar; 52(6):509-23. PubMed ID: 5452996
    [No Abstract]   [Full Text] [Related]  

  • 28. Experience with glibenclamide in three diabetic clinics.
    Brearley BF; Fawcitt RA; Hirst J
    Postgrad Med J; 1970 Dec; ():Suppl:60-2. PubMed ID: 5533300
    [No Abstract]   [Full Text] [Related]  

  • 29. [Trust is good, control is better. Glucose tests, insulin syringes, needles].
    Fink E
    Pharm Unserer Zeit; 2001 Jan; 30(1):34-9. PubMed ID: 11233181
    [No Abstract]   [Full Text] [Related]  

  • 30. [The geriatric diabetic patients. Pragmatic blood pressure control!].
    Meissner T
    MMW Fortschr Med; 2001 Aug; 143(33-34):61. PubMed ID: 11561468
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative investigations with Redul in sulfonylurea therapy].
    Stratmann FW
    Med Welt; 1967 Nov; 46():2794-5. PubMed ID: 5606416
    [No Abstract]   [Full Text] [Related]  

  • 32. Sliding-scale insulin: more evidence needed before final exit?
    Kitabchi AE; Nyenwe E
    Diabetes Care; 2007 Sep; 30(9):2409-10. PubMed ID: 17726192
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the treatment of diabetes mellitus with glycodiazin, an orally acting antidiabetic drug].
    Langsch HG; Bruns W
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):185-7. PubMed ID: 5595285
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of short-term effects of glibenclamide and chlorpropamide in newly diagnosed diabetics.
    FitzGerald MG; Malino JM
    Postgrad Med J; 1970 Dec; ():Suppl:57-9. PubMed ID: 5533299
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical study of glibenclamide, a new oral hypoglycemic agent].
    Iunes M; Mazzarollo DN; Reis LC
    AMB Rev Assoc Med Bras; 1971 May; 17(5):169-74. PubMed ID: 4997760
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of glibenclamide with other oral hypoglycaemic agents.
    Wetherill JH; Tunbridge RE
    Postgrad Med J; 1970 Dec; ():Suppl:88-91. PubMed ID: 5533304
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical evaluation of Daonil--a new sulphonylurea derivative].
    Nowotna-Walcowa R; Rozyńska E
    Pol Tyg Lek; 1971 Jan; 26(2):65-7. PubMed ID: 5101252
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical experience with glibenclamide in 300 diabetics.
    Beyer J; Schöffling K
    Postgrad Med J; 1970 Dec; ():Suppl:78-83. PubMed ID: 5500516
    [No Abstract]   [Full Text] [Related]  

  • 39. [Management of diabetes mellitus using orally effective, blood sugar reducing, drugs].
    Constam GR; Berger W
    Dtsch Med Wochenschr; 1967 Dec; 92(49):2278-80. PubMed ID: 6066358
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetes, Part 1. Understanding the pathophysiology of diabetes mellitus.
    Mattera CJ
    JEMS; 2002 Mar; 27(3):106-14, 116-24; quiz 126-7. PubMed ID: 11913177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.